Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Wellmarker Bio Co., LTD.”

3 pharma patents match "Wellmarker Bio Co., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Wellmarker Bio Co., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Wellmarker Bio Co., LTD.” · 30,257 patents in full index Clear search

  1. US 11447500

    Thienopyridine derivatives and pharmaceutical composition comprising same

    Wellmarker Bio Co., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  2. US 11186873

    Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

    Wellmarker Bio Co., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  3. US 11008622

    Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof

    Wellmarker Bio Co., LTD. · Granted May 18, 2021 · Expires May 13, 2041

    granted